Author: admin

HAIFA, Israel, Oct. 28, 2024 /PRNewswire/ — Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) (“Elbit Systems” or the “Company”) announced today that it was awarded an approximately $200 million contract by the Israeli Ministry of Defense (IMOD) to supply high-power laser

Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials6-12 Mounjaro represents a new class of obesity and diabetes medicines and is expected to be available in Hong

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: